Washington, D.C. — President Donald Trump’s assertion that Venezuelan President Nicolás Maduro has played a significant role in drug trafficking, particularly in the epidemic of opioid overdoses in the United States, is facing skepticism from experts in the field. Analysts from various government and independent organizations contend that Venezuela doesn’t significantly contribute to U.S. cocaine supplies and has no substantial connection to fentanyl trafficking, the primary driver of overdose deaths.
According to findings from the Drug Enforcement Administration (DEA), Venezuela is not identified as a source or transit country for fentanyl in its annual reports. Instead, the majority of this potent synthetic opioid is traced back to production in Mexico, where it is often smuggled into the U.S. by American citizens. Jeffrey Singer, a surgeon and senior fellow at the Cato Institute, stated that developments in Venezuela are unlikely to affect U.S. overdose rates, emphasizing that fentanyl remains the leading catalyst in the crisis.
The Centers for Disease Control and Prevention (CDC) reports that over 65% of overdose fatalities in 2024 involved illegally manufactured fentanyl. In sharp contrast, approximately 34% were linked to cocaine, a figure that includes cases involving multiple substances. Notably, only 20% of overdose deaths resulted solely from fentanyl, while 8.3% were attributed to cocaine.
The U.S. State Department has classified Venezuela as a significant transit hub for cocaine, which is predominantly produced in Colombia. However, experts like Vanda Felbab-Brown from the Brookings Institution point out that much of this cocaine is intended for European markets rather than the United States. She notes that a substantial amount bypasses Venezuela altogether, reaching U.S. shores by sea through alternative routes.
Questions also surround the narrative portraying Maduro as a mastermind of the drug trafficking ecosystem. Felbab-Brown suggests that while there may be awareness of government officials profiting from the drug trade, it is not commonly accepted that Maduro orchestrates these operations. The complexity of the drug trade and the entangled power dynamics in Venezuela make it difficult to pin comprehensive responsibility on a single individual.
As legal proceedings unfold in New York concerning Maduro, uncertainty remains about the U.S. government’s ability to substantiate charges against him. “It remains to be seen whether the prosecution will be able to validate those claims,” Felbab-Brown remarked, casting further doubt on the prevailing narrative.
Overall, the discussion underscores the need for a nuanced understanding of the intersection between international politics and drug trafficking. As the U.S. grapples with a public health crisis fueled mainly by fentanyl, the connection to Venezuela may not be as clear-cut as some policymakers suggest.